Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$257M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$254M |
| 3 |
Microsoft
MSFT
|
+$247M |
| 4 |
AerCap
AER
|
+$77.8M |
| 5 |
ON Semiconductor
ON
|
+$61.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$76.2M |
| 2 |
Diamondback Energy
FANG
|
+$44.8M |
| 3 |
Exelon
EXC
|
+$41.9M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$38.8M |
| 5 |
American Electric Power
AEP
|
+$38.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Industrials | 11.23% |
| 4 | Financials | 8.63% |
| 5 | Healthcare | 6.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Douglas Dynamics
PLOW
$961M
| $913K | 0.01% |
+23,366
| New | +$943K |
|
1127
Certara
CERT
$1.21B
| $907K | 0.01% |
+31,900
| New | +$1.07M |
|
1128
Zymeworks
ZYME
$2.06B
| $904K | 0.01% |
55,172
+11,047
| +25% | +$230K |
|
|
HR
1129
DELISTED
Healthcare Realty Trust Incorporated
HR
| $903K | 0.01% |
+28,528
| New | +$915K |
|
1130
MP Materials
MP
$10.2B
| $902K | 0.01% |
+19,868
| New | +$783K |
|
|
NVRO
1131
DELISTED
NEVRO CORP.
NVRO
| $900K | 0.01% |
11,106
+9,020
| +432% | +$904K |
|
|
EPZM
1132
DELISTED
Epizyme, Inc
EPZM
| $899K | 0.01% |
+359,472
| New | +$1.41M |
|
|
GTH
1133
DELISTED
Genetron Holdings Limited ADS
GTH
| $898K | 0.01% |
49,078
-4,616
| -9% | -$153K |
|
|
RAD
1134
DELISTED
Rite Aid Corporation
RAD
| $897K | 0.01% |
+61,084
| New | +$824K |
|
1135
EPR Properties
EPR
$4.64B
| $896K | 0.01% |
+18,866
| New | +$936K |
|
1136
EverCommerce
EVCM
$1.69B
| $896K | 0.01% |
56,897
+12,893
| +29% | +$230K |
|
1137
Sylvamo
SLVM
$1.47B
| $895K | 0.01% |
+32,082
| New | +$934K |
|
|
FMBI
1138
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $895K | 0.01% |
43,724
-25,340
| -37% | -$508K |
|
1139
First Majestic Silver
AG
$10.3B
| $893K | 0.01% |
80,337
+7,391
| +10% | +$89.2K |
|
1140
UGI
UGI
$8.19B
| $893K | 0.01% |
19,446
-8,727
| -31% | -$388K |
|
1141
Affiliated Managers Group
AMG
$9.28B
| $891K | 0.01% |
5,416
+2,118
| +64% | +$355K |
|
1142
Diodes
DIOD
$4.13B
| $889K | 0.01% |
+8,098
| New | +$821K |
|
|
INST
1143
DELISTED
Instructure Holdings, Inc.
INST
| $889K | 0.01% |
37,069
+6,548
| +21% | +$159K |
|
|
FOCS
1144
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $889K | 0.01% |
+14,878
| New | +$926K |
|
|
PARA
1145
DELISTED
Paramount Global Class B
PARA
| $882K | 0.01% |
29,214
-78,111
| -73% | -$2.69M |
|
|
COOP
1146
DELISTED
Mr. Cooper
COOP
| $881K | 0.01% |
+21,180
| New | +$891K |
|
1147
DNOW Inc
DNOW
$2.8B
| $880K | 0.01% |
103,072
+42,725
| +71% | +$370K |
|
1148
Moderna
MRNA
$55.4B
| $876K | 0.01% |
3,451
-74
| -2% | -$21.6K |
|
1149
O-I Glass
OI
$1.11B
| $875K | 0.01% |
72,722
+21,333
| +42% | +$270K |
|
|
PNT
1150
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $868K | 0.01% |
+155,034
| New | +$1.16M |
|
Similar funds
Michael Gelband's Q4 2021 Portfolio in Review
As of Q4 2021, Michael Gelband held 2,843 positions worth $9.67B, up 30% from $7.41B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Michael Gelband deployed $1.95B of net new capital in Q4 2021, opening 810 new positions and adding to 656 existing holdings. Its largest new stake was Amazon: 1,500,500 shares worth $250M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $76.2M trimmed.
- Michael Gelband's largest Q4 2021 buy was Amazon: 1,500,500 shares worth $250M.
- Michael Gelband added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $254M increase.
- Michael Gelband's biggest Q4 2021 reduction was Advanced Micro Devices, cutting an estimated $76.2M.
- Michael Gelband fully exited Diamondback Energy in Q4 2021, selling an estimated $44.8M.
- Michael Gelband's ten largest holdings make up 22% of its $9.67B portfolio in Q4 2021.
- Michael Gelband opened 810 new positions and closed 731 in Q4 2021.
- Michael Gelband's portfolio value rose 30% quarter-over-quarter to $9.67B.
Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.